Calidi Biotherapeutics logo

Calidi Biotherapeutics Share Price Today

(NASDAQ: CLDI)

Calidi Biotherapeutics share price is $0.87 & ₹75.75 as on 6 Mar 2025, 2.30 'hrs' IST

$0.87

0.06

(6.94%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Calidi Biotherapeutics share price in Dollar and Rupees. Guide to invest in Calidi Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Calidi Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Calidi Biotherapeutics share price movements

  • Today's Low: $0.77
    Today's High: $0.95

    Day's Volatility :19.26%

  • 52 Weeks Low: $0.58
    52 Weeks High: $8.30

    52 Weeks Volatility :93.01%

Calidi Biotherapeutics (CLDI) Returns

PeriodCalidi Biotherapeutics IncIndex (Russel 2000)
3 Months
-56.67%
0.0%
6 Months
-23.6%
0.0%
1 Year
-87.16%
0.0%
3 Years
-98.22%
-11.6%

Calidi Biotherapeutics (CLDI) Key Statistics

in dollars & INR

Previous Close
$0.8145
Open
$0.8442
Today's High
$0.95
Today's Low
$0.767
Market Capitalization
$24.6M
Today's Volume
$1.1M
52 Week High
$8.3
52 Week Low
$0.58
Revenue TTM
$0.0
EBITDA
$-29.2M
Earnings Per Share (EPS)
$-3.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Calidi Biotherapeutics Stock (CLDI) from India?

It is very easy for Indian residents to invest directly in Calidi Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Calidi Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Calidi Biotherapeutics or CLDI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Calidi Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Calidi Biotherapeutics shares which would translate to 1.001 fractional shares of Calidi Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Calidi Biotherapeutics, in just a few clicks!

Returns in Calidi Biotherapeutics (CLDI) for Indian investors in Rupees

The Calidi Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Calidi Biotherapeutics investment value today

Current value as on today

₹17,897

Returns

₹82,103

(-82.1%)

Returns from Calidi Biotherapeutics Stock

₹87,168 (-87.17%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Calidi Biotherapeutics (CLDI)

45%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Calidi Biotherapeutics Stock from India on INDmoney has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Calidi Biotherapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Calidi Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Calidi Biotherapeutics Stock (CLDI)

What analysts predicted

Upside of 618.39%

Target:

$6.25

Current:

$0.87

Insights on Calidi Biotherapeutics Stock (Ticker Symbol: CLDI)

  • Price Movement

    In the last 7 days, CLDI stock has moved up by 4.5%
  • CLDI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 153.7%

Calidi Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Calidi Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.

Calidi Biotherapeutics (CLDI) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Calidi Biotherapeutics Inc logo
-34.02%
-23.6%
-87.16%
-98.22%
-98.22%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Calidi Biotherapeutics Inc logo
NA
NA
NA
-3.97
0.0
-2.22
NA
-1.82
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Calidi Biotherapeutics Inc logo
Buy
$24.6M
-98.22%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Calidi Biotherapeutics

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California.
Organization
Calidi Biotherapeutics
Employees
41
CEO
Mr. Allan J. Camaisa
Industry
Miscellaneous

Management People of Calidi Biotherapeutics

NameTitle
Mr. Allan J. Camaisa
CEO & Chairman of the Board
Ms. Wendy Pizarro Campbell Esq.
Chief Legal, Chief Corporate Dev, Chief Diversity & Corp Sec. and Director
Dr. Boris Minev M.D., Ph.D.
President of Medical & Scientific Affairs and Interim Chief Medical Officer
Mr. Andrew C. Jackson
Chief Financial Officer
Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D.
Head of Technical Operations & Chief Scientific Officer
Dr. Thomas Herrmann
Managing Director of Process & Assay Development

Important FAQs about investing in CLDI Stock from India :

What is Calidi Biotherapeutics share price today?

Calidi Biotherapeutics share price today stands at $0.87, Open: $0.84 ; Previous Close: $0.81 ; High: $0.95 ; Low: $0.77 ; 52 Week High: $8.30 ; 52 Week Low: $0.58.

The stock opens at $0.84, after a previous close of $0.81. The stock reached a daily high of $0.95 and a low of $0.77, with a 52-week high of $8.30 and a 52-week low of $0.58.

Can Indians buy Calidi Biotherapeutics shares?

Yes, Indians can invest in the Calidi Biotherapeutics (CLDI) from India.

With INDmoney, you can buy Calidi Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Calidi Biotherapeutics at zero transaction cost.

How can I buy Calidi Biotherapeutics shares from India?

It is very easy to buy Calidi Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Calidi Biotherapeutics (CLDI) be purchased?

Yes, you can buy fractional shares of Calidi Biotherapeutics with INDmoney app.

What are the documents required to start investing in Calidi Biotherapeutics stocks?

To start investing in Calidi Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Calidi Biotherapeutics Stock (CLDI)?

Today’s highest price of Calidi Biotherapeutics (CLDI) is $0.95.

Today’s lowest price of Calidi Biotherapeutics (CLDI) is $0.77.

What is today's market capitalisation of Calidi Biotherapeutics?

Today's market capitalisation of Calidi Biotherapeutics CLDI is 24.6M

What is the 52 Week High and Low Range of Calidi Biotherapeutics Stock (CLDI)?

  • 52 Week High

    $8.30

  • 52 Week Low

    $0.58

What are the historical returns of Calidi Biotherapeutics (CLDI)?

  • 1 Month Returns

    -34.02%

  • 3 Months Returns

    -23.6%

  • 1 Year Returns

    -87.16%

  • 5 Years Returns

    -98.22%

Who is the Chief Executive Officer (CEO) of Calidi Biotherapeutics ?

Mr. Allan J. Camaisa is the current Chief Executive Officer (CEO) of Calidi Biotherapeutics.